Sandbox:Hannan: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 5: Line 5:
|-
|-
|'''Wingless and integration-1 (Wnt) signaling'''
|'''Wingless and integration-1 (Wnt) signaling'''
* '''Canonical pathway'''
'''Activation of Wnt pathway → binding of Wnt ligands to Wnt co-receptors LRP5/6 and one trans-membrane receptor of the FDZ family →'''  
'''Activation of Wnt pathway → binding of Wnt ligands to Wnt co-receptors LRP5/6 and one trans-membrane receptor of the FDZ family →'''  


Line 10: Line 11:


'''activation of T cell factor/lymphoid enhancer factor (TCF/LEF) transcription factors → ↑ bone formation and ↓ bone resorption'''
'''activation of T cell factor/lymphoid enhancer factor (TCF/LEF) transcription factors → ↑ bone formation and ↓ bone resorption'''
* Binding of PTH to PTH1 receptor may result in activation of same receptor
* '''Non-canonical WNT–planar cell polarity (WNT–PCP) pathway'''
'''Formation of WNT ligand–receptor tyrosine kinase-like orphan receptor 2 (ROR2) or the receptor-like tyrosine kinase (RYK)–FZD–DVL complex'''
 
'''→ activation of one of these 3 pathways: 1) Disheveled-associated activator of morphogenesis 1 (DAAM1)–RHO–RHO-associated kinase (ROCK) pathway; 2) RAC–Jun kinase (JNK)–RUNX2 pathway; WNT–Ca<sup>2+</sup> pathway'''
* Binding of PTH to PTH1 receptor may result in activation of Wnt pathway
* This pathway is also involved in cell-cycle promotion and cell growth
* This pathway is also involved in cell-cycle promotion and cell growth
*  
*  

Revision as of 19:37, 29 October 2018

Molecular pathways and factors associated with osteoblastic activity Association with multiple myeloma
Wingless and integration-1 (Wnt) signaling
  • Canonical pathway

Activation of Wnt pathway → binding of Wnt ligands to Wnt co-receptors LRP5/6 and one trans-membrane receptor of the FDZ family →

formation of DVL–Axin–FRAT1–GSK-3β complex → translocation of β-catenin from cytoplasm to nucleus →

activation of T cell factor/lymphoid enhancer factor (TCF/LEF) transcription factors → ↑ bone formation and ↓ bone resorption

  • Non-canonical WNT–planar cell polarity (WNT–PCP) pathway

Formation of WNT ligand–receptor tyrosine kinase-like orphan receptor 2 (ROR2) or the receptor-like tyrosine kinase (RYK)–FZD–DVL complex

→ activation of one of these 3 pathways: 1) Disheveled-associated activator of morphogenesis 1 (DAAM1)–RHO–RHO-associated kinase (ROCK) pathway; 2) RAC–Jun kinase (JNK)–RUNX2 pathway; WNT–Ca2+ pathway

  • Binding of PTH to PTH1 receptor may result in activation of Wnt pathway
  • This pathway is also involved in cell-cycle promotion and cell growth
Dickkopf 1 (Dkk-1)
  • an extracellular inhibitor of this pathway expressed by osteoblasts and bone marrow stromal cells, is thought to play the crucial role in osteoblastic inhibition in multiple myeloma.
  • The serum levels and the expression of Dickkopf 1 (Dkk-1) by bone marrow cells were found to increased in patients with multiple myeloma.

Sclerostin

  • secreted by osteocytes, sclerostin is a cysteine knot-containing protein
  • activates the caspase pathway, resulting in apoptosis of mature osteoblasts
  • binds to LRP5/6 transmembrane receptors preventing the Wnt ligand- LRP5/6 transmembrane receptors binding, that leads to inhibition of Wnt signaling pathway
  • promotes osteoclastogenesis by increasing RANKL/OPG ratio
  • elevated levels have been found in all phases of multiple myeloma and is considered to be a worse prognosis factor. Furthermore, myeloma cells have been shown to secrete sclerostin

Secreted frizzled related protein-2 (sFRP-2)

  • prevents binding of Wnt ligands to frizzled, a membrane bound receptor
  • some studies suggest that myeloma cells express sFRP-2 that antagonizes bone formation

Periostin

  • produced by bone marrow stromal cells, periostin is an adhesion protein of fasciclin family
  • thought to activate the integrin–AKT–FAK–β-catenin pathway
  • although the role is still unclear, elevated levels have been found in almost all the patients presenting with multiple myeloma
Transforming Growth Factor-β
  • a ubiquitous, multifunctional growth factor
  • produced by osteocytes and osteoblasts and is activated by osteoclasts
  • primary effect in bone marrow is the inhibition of terminal differentiation of osteoblasts